Table of Contents Author Guidelines Submit a Manuscript
Pathology Research International
Volume 2011, Article ID 109712, 8 pages
http://dx.doi.org/10.4061/2011/109712
Review Article

Sentinel Node Biopsy for Breast Cancer Patients: Issues for Discussion and Our Practice

“Prolipsis” Diagnostic Center, Breast Unit, 88A Mihalacopoulou Street, 11528 Athens, Greece

Received 14 September 2010; Accepted 9 December 2010

Academic Editor: Nicole Nicosia Esposito

Copyright © 2011 Georgios Pechlivanides et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Ashikaga, D. N. Krag, S. R. Land et al., “Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection,” Journal of Surgical Oncology, vol. 102, no. 2, pp. 111–118, 2010. View at Publisher · View at Google Scholar · View at PubMed
  2. G. H. Lyman, A. E. Giuliano, M. R. Somerfield et al., “American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer,” Journal of Clinical Oncology, vol. 23, no. 30, pp. 7703–7720, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. M. A. Lynch, J. Jackson, J. A. Kim, and R. A. Leeming, “Optimal number of radioactive sentinel lymph nodes to remove for accurate axillary staging of breast cancer,” Surgery, vol. 144, no. 4, pp. 525–532, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. H. Takei, M. Kurosumi, T. Yoshida et al., “Current trends of sentinel lymph node biopsy for breast cancer–a surgeon's perspective,” Breast Cancer, vol. 14, no. 4, pp. 362–370, 2007. View at Google Scholar · View at Scopus
  5. M. C. Specht, J. V. Fey, P. I. Borgen, and H. S. Cody, “Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?” Journal of the American College of Surgeons, vol. 200, no. 1, pp. 10–14, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. M. Intra, N. Rotmensz, D. Mattar et al., “Unnecessary axillary node dissections in the sentinel lymph node era,” European Journal of Cancer, vol. 43, no. 18, pp. 2664–2668, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. F. Tresserra, I. Rodriguez, M. García-Yuste, P. J. Grases, C. Ara, and R. Fabregas, “Tumor size and lymph node status in multifocal breast cancer,” Breast Journal, vol. 13, no. 1, pp. 68–71, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. A. Ferrari, P. Dionigi, F. Rovera et al., “Multifocality and multicentricity are not contraindications for sentinel lymph node biopsy in breast cancer surgery,” World Journal of Surgical Oncology, vol. 4, article 79, 2006. View at Publisher · View at Google Scholar · View at PubMed
  9. S. Giard, M. -P. Chauvet, N. Penel et al., “Feasibility of sentinel lymph node biopsy in multiple unilateral synchronous breast cancer: results of a French prospective multi-institutional study (IGASSU 0502),” Annals of Oncology, vol. 21, no. 8, pp. 1630–1635, 2010. View at Publisher · View at Google Scholar · View at PubMed
  10. E. E. Deurloo, P. J. Tanis, K. G. A. Gilhuijs et al., “Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancer,” European Journal of Cancer, vol. 39, no. 8, pp. 1068–1073, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. S. L. Koelliker, M. A. Chung, M. B. Mainiero, M. M. Steinhoff, and B. Cady, “Axillary lymph nodes: US guided fine-needle aspiration for initial staging of breast cancer—correlation with primary tumor size,” Radiology, vol. 246, no. 1, pp. 81–89, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. J. Jung, H. Park, J. Park, and H. Kim, “Accuracy of preoperative ultrasound and ultrasound-guided fine needle aspiration cytology for axillary staging in breast cancer,” ANZ Journal of Surgery, vol. 80, no. 4, pp. 271–275, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. M. C. Lee, J. Eatrides, A. Chau et al., “Consequences of axillary ultrasound in patients with T2 or greater invasive breast cancers,” Annals of Surgical Oncology. In press. View at Publisher · View at Google Scholar · View at PubMed
  14. M. J. Garcia-Ortega, M. A. Benito, E. F. Vahamonde, P. R. Torres, A. B. Velasco, and M. M. Paredes, “Pretreatment axillary ultrasonography and core biopsy in patients with suspected breast cancer: diagnostic accuracy and impact on management,” European Journal of Radiology. In press. View at Publisher · View at Google Scholar · View at PubMed
  15. U. Veronesi, C. De Cicco, V. E. Galimberti et al., “A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases,” Annals of Oncology, vol. 18, no. 3, pp. 473–478, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. H. M. Kuerer and K. K. Hunt, “The rationale for integration of lymphatic mapping and sentinel node biopsy in the management of breast cancer after neoadjuvant chemotherapy,” Seminars in Breast Disease, vol. 5, no. 2, pp. 80–87, 2002. View at Google Scholar · View at Scopus
  17. F. E. Sharkey, S. L. Addington, L. J. Fowler, C. P. Page, and A. B. Cruz, “Effects of preoperative chemotherapy on the morphology of resectable breast carcinoma,” Modern Pathology, vol. 9, no. 9, pp. 893–900, 1996. View at Google Scholar · View at Scopus
  18. M. Fraile, M. Rull, F. J. Julián et al., “Sentinel node biopsy as a practical alternative to axillary lymph node dissection in breast cancer patients: an approach to its validity,” Annals of Oncology, vol. 11, no. 6, pp. 701–705, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. D. M. Miltenburg, C. Miller, T. B. Karamlou, and F. C. Brunicardi, “Meta-analysis of sentinel lymph node biopsy in breast cancer,” Journal of Surgical Research, vol. 84, no. 2, pp. 138–142, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. T. Kim, A. E. Giuliano, and G. H. Lyman, “Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis,” Cancer, vol. 106, no. 1, pp. 4–16, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. Y. Xing, M. Foy, D. D. Cox, H. M. Kuerer, K. K. Hunt, and J. N. Cormier, “Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer,” British Journal of Surgery, vol. 93, no. 5, pp. 539–546, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. T. Kim, O. Agboola, and G. H. Lyman, “Lymphatic mapping and sentinel lymph node sampling in breast cancer: a meta-analysis,” in ASCO Annual Meeting Proceedings, Orlando, Fla, USA, 2002.
  23. D. M. Miltenburg, C. Miller, T. B. Karamlou, and F. C. Brunicardi, “Meta-analysis of sentinel lymph node biopsy in breast cancer,” Journal of Surgical Research, vol. 84, no. 2, pp. 138–142, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. J. Shen, M. Z. Gilcrease, G. V. Babiera et al., “Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases,” Cancer, vol. 109, no. 7, pp. 1255–1263, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. G. F. Schwartz, J. E. Tannebaum, A. M. Jernigan, and J. P. Palazzo, “Axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for carcinoma of the breast,” Cancer, vol. 116, no. 5, pp. 1243–1251, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. K. Shimazu, Y. Tamaki, T. Taguchi, F. Tsukamoto, T. Kasugai, and S. Noguchi, “Intraoperative frozen section analysis of sentinel lymph node in breast cancer patients treated with neoadjuvant chemotherapy,” Annals of Surgical Oncology, vol. 15, no. 6, pp. 1717–1722, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. H. Iwase, Y. Yamamoto, T. Kawasoe, and M. Ibusuki, “Advantage of sentinel lymph node biopsy before neoadjuvant chemotherapy in breast cancer treatment,” Surgery Today, vol. 39, no. 5, pp. 374–380, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. T. W. F. Yen, K. K. Hunt, M. I. Ross et al., “Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ,” Journal of the American College of Surgeons, vol. 200, no. 4, pp. 516–526, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. C. B. Teal, J. P. Slocum, E. A. Akin, and T. A. Kelly, “Correlation of lymphoscintigraphy with the number of sentinel lymph nodes identified intraoperatively in patients with breast cancer,” American Journal of Surgery, vol. 190, no. 4, pp. 567–569, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. M. Carmon, D. Hain, J. Shapira, and E. Golomb, “Preoperative lymphatic mapping does not predict the number of axillary sentinel lymph nodes identified during surgery in breast cancer patients,” Breast Journal, vol. 12, no. 5, pp. 424–427, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. A. B. Chagpar, D. J. Carlson, A. L. Laidley et al., “Factors influencing the number of sentinel lymph nodes identified in patients with breast cancer,” American Journal of Surgery, vol. 194, no. 6, pp. 860–865, 2007. View at Publisher · View at Google Scholar · View at PubMed
  32. K. S. S. Low and D. R. G. Littlejohn, “Optimal number of sentinel nodes after intradermal injection isotope and blue dye,” ANZ Journal of Surgery, vol. 76, no. 6, pp. 472–475, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. S. L. Wong, M. J. Edwards, C. Chao et al., “Sentinel lymph node biopsy for breast cancer: impact of the number of sentinel nodes removed on the false-negative rate,” Journal of the American College of Surgeons, vol. 192, no. 6, pp. 684–691, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Zavagno, G. L. De Salvo, F. Bozza et al., “Number of metastatic sentinel nodes as predictor of axillary involvement in patients with breast cancer,” Breast Cancer Research and Treatment, vol. 86, no. 2, pp. 171–179, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. Y. Y. Tan, Y. G. Fan, Y. Lu et al., “Ratio of positive to total number of sentinel nodes predicts nonsentinel node status in breast cancer patients,” Breast Journal, vol. 11, no. 4, pp. 248–253, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. E. Samoilova, J. T. Davis, J. Hinson et al., “Size of sentinel node tumor deposits and extent of axillary lymph node involvement: which breast cancer patients may benefit from less aggressive axillary dissections?” Annals of Surgical Oncology, vol. 14, no. 8, pp. 2221–2227, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. C. Coutant, C. Olivier, E. Lambaudie et al., “Comparison of models to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a prospective multicenter study,” Journal of Clinical Oncology, vol. 27, no. 17, pp. 2800–2808, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. T. Fujii, Y. Yanagita, T. Fujisawa, T. Hirakata, M. Iijima, and H. Kuwano, “Implication of extracapsular invasion of sentinel lymph nodes in breast cancer: prediction of nonsentinel lymph node metastasis,” World Journal of Surgery, vol. 34, no. 3, pp. 544–548, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. S. Holck, H. Galatius, U. Engel, F. Wagner, and J. Hoffmann, “False-negative frozen section of sentinel lymph node biopsy for breast cancer,” Breast, vol. 13, no. 1, pp. 42–48, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. M. Mori, K. Tada, M. Ikenaga et al., “Frozen section is superior to imprint cytology for the intra-operative assessment of sentinel lymph node metastasis in stage I Breast cancer patients,” World Journal of Surgical Oncology, vol. 4, article 26, 2006. View at Publisher · View at Google Scholar · View at PubMed
  41. J. E. Lang, L. C. Liu, Y. Lu et al., “Sensitivity of intraoperative frozen-section evaluation of sentinel lymph nodes for breast cancer,” in Breast Cancer Symposium, 2009, abstract no 45.
  42. K. Tew, L. Irwig, A. Matthews, P. Crowe, and P. Macaskill, “Meta-analysis of sentinel node imprint cytology in breast cancer,” British Journal of Surgery, vol. 92, no. 9, pp. 1068–1080, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. S. Krishnamurthy, F. Meric-Bernstam, A. Lucci et al., “A prospective study comparing touch imprint cytology, frozen section analysis, and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lymph nodes in breast cancer,” Cancer, vol. 115, no. 7, pp. 1555–1562, 2009. View at Publisher · View at Google Scholar · View at PubMed
  44. Y. J. Choi, H. R. Yun, K. E. Yoo et al., “Intraoperative examination of sentinel lymph nodes by ultrarapid immunohistochemistry in breast cancer,” Japanese Journal of Clinical Oncology, vol. 36, no. 8, pp. 489–493, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. J. M. Nährig, T. Richter, W. Kuhn et al., “Intraoperative examination of sentinel lymph nodes by ultrarapid immunohistochemistry,” Breast Journal, vol. 9, no. 4, pp. 277–281, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Nährig, T. Richter, J. Kowolik et al., “Comparison of different histopathological methods for the examination of sentinel lymphnodes in breast cancer,” Anticancer Research, vol. 20, no. 3 B, pp. 2209–2212, 2000. View at Google Scholar · View at Scopus
  47. M. Tsujimoto, K. Nakabayashi, K. Yoshidome et al., “One-step nucleic acid amplification for intraoperative detection of lymph node metastasis in breast cancer patients,” Clinical Cancer Research, vol. 13, no. 16, pp. 4807–4816, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. D. J. Dabbs, M. Fung, D. Landsittel, K. McManus, and R. Johnson, “Sentinel lymph node micrometastasis as a predictor of axillary tumor burden,” Breast Journal, vol. 10, no. 2, pp. 101–105, 2004. View at Publisher · View at Google Scholar · View at Scopus
  49. G. Cserni, S. Bianchi, V. Vezzosi et al., “Variations in sentinel node isolated tumour cells/micrometastasis and non-sentinel node involvement rates according to different interpretations of the TNM definitions,” European Journal of Cancer, vol. 44, no. 15, pp. 2185–2191, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. M. de Boer, C. H. M. van Deurzen, J. A. A. M. van Dijck et al., “Micrometastases or isolated tumor cells and the outcome of breast cancer,” The New England Journal of Medicine, vol. 361, no. 7, pp. 653–663, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  51. P. T. Truong, V. Vinh-Hung, G. Cserni, W. A. Woodward, P. Tai, and G. Vlastos, “The number of positive nodes and the ratio of positive to excised nodes are significant predictors of survival in women with micrometastatic node-positive breast cancer,” European Journal of Cancer, vol. 44, no. 12, pp. 1670–1677, 2008. View at Publisher · View at Google Scholar · View at PubMed
  52. D. Park, R. Kåresen, B. Naume, M. Synnestvedt, E. Beraki, and T. Sauer, “The prognostic impact of occult nodal metastasis in early breast carcinoma,” Breast Cancer Research and Treatment, vol. 118, no. 1, pp. 57–66, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  53. S. Yegiyants, L. M. Romero, P. I. Haigh, and L. A. DiFronzo, “Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node,” Archives of Surgery, vol. 145, no. 6, pp. 564–569, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  54. M. S. Pugliese, A. K. Karam, M. Hsu et al., “Predictors of completion axillary lymph node dissection in patients with immunohistochemical metastases to the sentinel lymph node in breast cancer,” Annals of Surgical Oncology, vol. 17, no. 4, pp. 1063–1068, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  55. P. Meijnen, J. L. Peterse, O. E. Nieweg, and E. J. T. Rutgers, “Detailed pathological examination of the sentinel lymph nodes in order to detect micrometastases: no clinical relevance in patients with breast cancer,” Nederlands Tijdschrift voor Geneeskunde, vol. 148, no. 49, pp. 2428–2432, 2004. View at Google Scholar · View at Scopus
  56. A. S. Pargaonkar, R. S. Beissner, S. Snyder, and V. O. Speights, “Evaluation of immunohistochemistry and multiple-level sectioning in sentinel lymph nodes from patients with breast cancer,” Archives of Pathology and Laboratory Medicine, vol. 127, no. 6, pp. 701–705, 2003. View at Google Scholar · View at Scopus
  57. U. Veronesi, G. Paganelli, G. Viale et al., “A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer,” The New England Journal of Medicine, vol. 349, no. 6, pp. 546–553, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  58. G. Viale, S. Bosari, G. Mazzarol et al., “Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients,” Cancer, vol. 85, no. 11, pp. 2433–2438, 1999. View at Publisher · View at Google Scholar · View at Scopus
  59. J. L. B. Bevilacqua, G. Gucciardo, H. S. Cody et al., “A selection algorithm for internal mammary sentinel lymph node biopsy in breast cancer,” European Journal of Surgical Oncology, vol. 28, no. 6, pp. 603–614, 2002. View at Publisher · View at Google Scholar · View at Scopus
  60. J. C. Bourre, R. Payan, D. Collomb et al., “Can the sentinel lymph node technique affect decisions to offer internal mammary chain irradiation?” European Journal of Nuclear Medicine and Molecular Imaging, vol. 36, no. 5, pp. 758–764, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  61. S. H. Estourgie, P. J. Tanis, O. E. Nieweg, R. A. Valdés Olmos, E. J. T. Rutgers, and B. B. R. Kroon, “Should the hunt for internal mammary chain sentinel nodes begin? An evaluation of 150 breast cancer patients,” Annals of Surgical Oncology, vol. 10, no. 8, pp. 935–941, 2003. View at Publisher · View at Google Scholar · View at Scopus
  62. V. Galimberti, P. Veronesi, P. Arnone et al., “Stage migration after biopsy of internal mammary chain lymph nodes in breast cancer patients,” Annals of Surgical Oncology, vol. 9, no. 9, pp. 924–928, 2002. View at Google Scholar · View at Scopus
  63. C. S. E. Bulte, M. van der Heiden-van der Loo, and A. Hennipman, “Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study,” European Journal of Surgical Oncology, vol. 35, no. 1, pp. 25–31, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  64. D. M. Holwitt, W. E. Gillanders, R. L. Aft, T. J. Eberlein, and J. A. Margenthaler, “Sentinel lymph node biopsy in patients with multicentric/multifocal breast cancer: low false-negative rate and lack of axillary recurrence,” American Journal of Surgery, vol. 196, no. 4, pp. 562–565, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  65. I. M. C. van der Ploeg, O. E. Nieweg, M. C. van Rijk, R. A. Valdés Olmos, and B. B. R. Kroon, “Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: a systematic review and meta-analysis of the literature,” European Journal of Surgical Oncology, vol. 34, no. 12, pp. 1277–1284, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus